# Evaluation of the Hypoglycaemia Notification Device Hyposafe H02

> **NCT02925676** · NA · TERMINATED · sponsor: **UNEEG Medical A/S** · enrollment: 8 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** hyposafe H02

## Key facts

- **NCT ID:** NCT02925676
- **Lead sponsor:** UNEEG Medical A/S
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10-05
- **Primary completion:** 2018-08-29
- **Final completion:** 2018-09-10
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02925676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02925676, "Evaluation of the Hypoglycaemia Notification Device Hyposafe H02". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02925676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*